11 – 20 of 108
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Occupational risk of COVID-19 related hospital admission in Denmark 2020–2021 : a follow-up study
(
- Contribution to journal › Article
-
Mark
Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses
(
- Contribution to journal › Article
-
Mark
Longitudinal single-cell analysis of SARS-CoV-2-reactive B cells uncovers persistence of early-formed, antigen-specific clones
(
- Contribution to journal › Article
-
Mark
Third dose mRNA vaccination against SARS-CoV-2 reduces medical complaints seen in primary care : a matched cohort study
(
- Contribution to journal › Article
-
Mark
The prevalence of adverse reactions among individuals with three-dose COVID-19 vaccination
(
- Contribution to journal › Article
-
Mark
Impact of the gut microbiome on immunological responses to COVID-19 vaccination in healthy controls and people living with HIV
(
- Contribution to journal › Article
-
Mark
Inhaled ciclesonide in adults hospitalised with COVID-19 : a randomised controlled open-label trial (HALT COVID-19)
(
- Contribution to journal › Article
-
Mark
Subclass-switched anti-Spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization
(
- Contribution to journal › Article
-
Mark
High Exposure to Perfluoroalkyl Substances and Antibody Responses to SARS-CoV-2 mRNA Vaccine-an Observational Study in Adults from Ronneby, Sweden
(
- Contribution to journal › Article
-
Mark
COVID-19 hospitalization outcomes in adults by HIV status; a nation-wide register-based study
(
- Contribution to journal › Article